Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling
- PMID: 21294123
- DOI: 10.1002/path.2823
Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling
Abstract
We performed comprehensive genome-wide gene expression profiling (GEP) of extranodal nasal-type natural killer/T-cell lymphoma (NKTL) using formalin-fixed, paraffin-embedded tissue (n = 9) and NK cell lines (n = 5) in comparison with normal NK cells, with the objective of understanding the oncogenic pathways involved in the pathogenesis of NKTL and to identify potential therapeutic targets. Pathway and network analysis of genes differentially expressed between NKTL and normal NK cells revealed significant enrichment for cell cycle-related genes and pathways, such as PLK1, CDK1, and Aurora-A. Furthermore, our results demonstrated a pro-proliferative and anti-apoptotic phenotype in NKTL characterized by activation of Myc and nuclear factor kappa B (NF-κB), and deregulation of p53. In corroboration with GEP findings, a significant percentage of NKTLs (n = 33) overexpressed c-Myc (45.4%), p53 (87.9%), and NF-κB p50 (67.7%) on immunohistochemistry using a tissue microarray containing 33 NKTL samples. Notably, overexpression of survivin was observed in 97% of cases. Based on our findings, we propose a model of NKTL pathogenesis where deregulation of p53 together with activation of Myc and NF-κB, possibly driven by EBV LMP-1, results in the cumulative up-regulation of survivin. Down-regulation of survivin with Terameprocol (EM-1421, a survivin inhibitor) results in reduced cell viability and increased apoptosis in tumour cells, suggesting that targeting survivin may be a potential novel therapeutic strategy in NKTL.
Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Similar articles
-
The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.J Pathol. 2007 Oct;213(2):170-9. doi: 10.1002/path.2219. J Pathol. 2007. PMID: 17768706
-
LMP-1 induces survivin expression to inhibit cell apoptosis through the NF-κB and PI3K/Akt signaling pathways in nasal NK/T-cell lymphoma.Oncol Rep. 2015 May;33(5):2253-60. doi: 10.3892/or.2015.3847. Epub 2015 Mar 10. Oncol Rep. 2015. PMID: 25760809
-
NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.Jpn J Clin Oncol. 2009 Jul;39(7):418-24. doi: 10.1093/jjco/hyp037. Epub 2009 Apr 24. Jpn J Clin Oncol. 2009. PMID: 19395464
-
Survivin-dependent and -independent pathways and the induction of cancer cell death by tetra-O-methyl nordihydroguaiaretic acid.Semin Oncol. 2006 Aug;33(4):479-85. doi: 10.1053/j.seminoncol.2006.04.010. Semin Oncol. 2006. PMID: 16890802 Review.
-
Extranodal NK/T cell lymphoma, nasal type, presenting with primary cutaneous lesion mimicking granulomatous panniculitis: a case report and review of literature.J Med Assoc Thai. 2010 Aug;93(8):1001-7. J Med Assoc Thai. 2010. PMID: 20718178 Review.
Cited by
-
Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma.Cancers (Basel). 2023 Feb 21;15(5):1366. doi: 10.3390/cancers15051366. Cancers (Basel). 2023. PMID: 36900160 Free PMC article. Review.
-
Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regime.Mol Ther Oncolytics. 2022 May 4;25:288-304. doi: 10.1016/j.omto.2022.04.012. eCollection 2022 Jun 16. Mol Ther Oncolytics. 2022. PMID: 35663228 Free PMC article.
-
Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).Discov Med. 2017 Mar;23(126):189-199. Discov Med. 2017. PMID: 28472613 Free PMC article. Review.
-
RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.Leukemia. 2017 Oct;31(10):2219-2227. doi: 10.1038/leu.2017.40. Epub 2017 Jan 25. Leukemia. 2017. PMID: 28119527 Free PMC article.
-
PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.J Hematol Oncol. 2016 Oct 13;9(1):109. doi: 10.1186/s13045-016-0341-7. J Hematol Oncol. 2016. PMID: 27737703 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous